- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis ; volume:10 ; number:1 ; day:29 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
Acta Neuropathologica Communications ; 10, Heft 1 (29.10.2022), 1-11, 12.2022
- Creator
-
Teske, Nina C.
Engelen-Lee, Joo-Yeon
Dyckhoff-Shen, Susanne
Pfister, Hans-Walter
Klein, Matthias
Beek, Diederik van de
Kirschning, Carsten K.
Koedel, Uwe
Brouwer, Matthijs C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-022-01461-1
- URN
-
urn:nbn:de:101:1-2023011409211687273170
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Teske, Nina C.
- Engelen-Lee, Joo-Yeon
- Dyckhoff-Shen, Susanne
- Pfister, Hans-Walter
- Klein, Matthias
- Beek, Diederik van de
- Kirschning, Carsten K.
- Koedel, Uwe
- Brouwer, Matthijs C.
- SpringerLink (Online service)
Other Objects (12)
Influence of delivery on plasminogen activator inhibitor activity
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis.
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
Influence of delivery on plasminogen activator inhibitor activity
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis.
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
Influence of delivery on plasminogen activator inhibitor activity
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis.
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)